Community Healthcare Trust Q3 2026 earnings
Revenue and AFFO per share grew sequentially, supported by a lower G&A expense and a $31.5 million capital recycling disposition.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $32.4M | +4.8% | +3.9% | Ex. 99.1, income statement |
| EPS (GAAP) | $0.09 | +200.0% | +50.0% | Ex. 99.1, income statement |
| EPS (adjusted) | $0.58 | +3.6% | +3.6% | Ex. 99.1, income statement |
| Net income | $3.1M | +87.3% | +30.0% | Ex. 99.1, income statement |
Revenue breakdown
not stated in the 8-K
Margins and costs
- Gross margin 81.8% (prior 81.1%, change +0.7 pp)
- Operating expenses $20.8M (+14.3% YoY)
- One-offs in the quarter Gain (loss), net of impairment, on the sale of real estate assets: -$1.0M; Deferred compensation expense reduction: -$0.9M
- Effective tax rate N/A
- Non-GAAP bridge Adds back non-cash stock-based compensation ($1.9M) and deferred tax (expense) to arrive at Adjusted EBITDAre; adds back stock-based compensation to arrive at FFO.
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| Leased occupancy | 90.1% | 89.8% | N/A | +0.3 pp |
| Total real estate properties | 1,219,312 | 1,241,615 | 1,190,151 | -22,303 |
| Cash and cash equivalents | 1,350 | 2,673 | 3,383 | -1,323 |
Guidance
not stated in the 8-K
What drove it
- Revenue story Rental income grew $1.2M (+4%) YoY to $32.2M; total revenue grew $1.2M (+4%) YoY to $32.4M.
- EPS story EPS growth driven by higher net income and a lower tax rate (benefit of $12k vs prior year), offset by higher share count.
- One-off check Gain/loss on sale of real estate assets: -$1.0M; Deferred compensation expense reduction: -$0.9M.
The good
- AFFO per share increased 3.6% YoY to $0.58
- Leased occupancy improved to 90.1%
- General and administrative expenses declined 14.3% YoY to $4.2M
The bad
- Net debt increased to $558.4M (+0.2% YoY)
- Total real estate properties decreased 1.8% YoY to 1,219 properties
The ugly
- none
Open questions
- The timing and certainty of the $99M acquisition pipeline and the sale of the tenant's business remain uncertain.
- The company did not provide guidance for the fiscal year.
Full release
Community Healthcare Trust (CHCT) earnings release, November 3, 2026
News Release
Community Healthcare Trust Announces Results for the Three Months Ended September 30, 2026
FRANKLIN, Tenn., November 3, 2026 / PRNewswire / -- Community Healthcare Trust Incorporated (NYSE:
CHCT) (the "Company") today announced results for the three months ended September 30, 2026. The Company reported net income for the three months ended September 30, 2026 of approximately $3.1 million, or $0.09 per diluted common share. Funds from operations ("FFO") and adjusted funds from operations ("AFFO") for the three months ended September 30, 2026 totaled $0.54 and $0.58 per diluted common share, respectively.
Highlights Include:
Executing on Strategic Plan
The Company’s results for the three months ended September 30, 2026 reflect measurable progress executing the Strategic Plan announced August 4, 2026. Key operational and financial highlights from the second quarter of 2026 to the third quarter of 2026 include total revenue growth of $1.2 million or 4%, leased occupancy growth from 89.8% to 90.1%, and general and administrative expense decline of $0.7 million or 14.3%. On a year-over-year basis, FFO per share increased by $0.04 or 8.0%, while AFFO per share increased by $0.02 or 3.6%. Additionally, since the close of the second quarter of 2026, the Company has completed $32.3 million in property dispositions to support ongoing strategic capital recycling.
Dividend
On November 3, 2026, the Company's Board of Directors declared a quarterly common stock dividend in the amount of $0.33 per share, payable on November 25, 2026, to stockholders of record as of November 13, 2026. This is the same quarterly common stock dividend amount as the prior quarter.
Items Impacting Our Results
• Net income and FFO for the three months ended September 30, 2026 were impacted by a reduction in deferred compensation expense, included in general and administrative expenses, totaling approximately $0.9 million in the third quarter of 2026 compared to the second quarter of 2026. The decrease in deferred compensation expense was generally due to fully amortized restricted stock awards and forfeited performance-based restricted stock units at June 30, 2026 totaling approximately $1.25 million, offset partially by an increase in amortization due to restricted stock awards and units granted during the third quarter 2026 totaling approximately $0.4 million.
• During the third quarter of 2026, the geriatric behavioral hospital operator, a tenant in six of the Company's properties, paid approximately $0.5 million in rent, an increase of approximately $0.2 million from the second quarter of 2026. The tenant previously signed a Letter of Intent (LOI) in July 2025 to sell its business to a behavioral healthcare provider. The prospective buyer is finalizing legal and business due diligence and drafting definitive purchase agreements, which include new leases for the six hospital properties owned by the Company. While the transaction is progressing, the Company cannot provide assurance regarding the specific timing or the ultimate certainty of the closing.
• During the third quarter of 2026, the Company sold a property, received net proceeds of approximately $0.1 million, and recorded a $0.7 million loss on sale.
• The Company has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $99.0 million. The Company's expected returns on these investments are approximately 9.1% to 9.75%. The Company anticipates closing on the first of these properties in the fourth quarter of 2026, a second in the first quarter of 2027, and the remaining two between mid-2027 and early 2028; however, the Company cannot provide assurance as to the timing of when, or whether, these transactions will actually close.¹
• During the third quarter of 2026, the Company did not issue any shares under its ATM program.
• Subsequent to September 30, 2026, the Company sold two properties as part of the Company's capital recycling program for net proceeds totaling approximately $31.5 million. The proceeds are expected to fund acquisitions through like-kind exchange under Section 1031 and to be used for general corporate purposes.
About Community Healthcare Trust Incorporated
Community Healthcare Trust Incorporated is a real estate investment trust that focuses on owning income-producing real estate properties associated primarily with the delivery of outpatient healthcare services in our target sub-markets throughout the United States. As of September 30, 2026, the Company had investments of approximately $1.2 billion in 196 real estate properties (including one property with sales-type leases and two properties classified as assets held for sale). The properties are located in 36 states, totaling approximately 4.5 million square feet in the aggregate.
Additional information regarding the Company, including this quarter's operations, can be found at www.chct.reit. Please contact the Company at 615-771-3052 to request a printed copy of this information.
Financial statements
Income Statement
Statements Of Operations Items — (Amounts in thousands, except per share data)
| 3Q 2026 | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | |
|---|---|---|---|---|---|
| Revenues | 32,443 | 31,224 | 31,524 | 30,946 | 31,086 |
| Net income (loss) | 3,068 | 2,364 | 2,548 | 14,428 | 1,640 |
| NOI | 26,468 | 25,359 | 25,155 | 24,932 | 25,156 |
| EBITDAre | 22,290 | 20,472 | 20,050 | 20,173 | 20,505 |
| Adjusted EBITDAre | 24,193 | 23,250 | 22,761 | 22,772 | 22,970 |
| FFO | 14,960 | 13,218 | 13,399 | 13,329 | 13,547 |
| AFFO | 16,017 | 15,405 | 15,350 | 14,943 | 15,099 |
| FAD | 11,786 | 12,994 | 13,313 | 11,578 | 11,863 |
| Per Diluted Share: | |||||
| Net income (loss) attributable to common shareholders | 0.09 | 0.06 | 0.07 | 0.51 | 0.03 |
| FFO | 0.54 | 0.48 | 0.49 | 0.49 | 0.5 |
| AFFO | 0.58 | 0.56 | 0.56 | 0.55 | 0.56 |
| Balance Sheet Items | 3Q 2026 | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 |
| Assets | |||||
| Total real estate properties | 1,219,312 | 1,241,615 | 1,238,080 | 1,203,229 | 1,190,151 |
| Total assets | 1,000,411 | 1,003,595 | 1,010,093 | 990,757 | 987,261 |
| Capitalization | |||||
| Net debt | 558,382 | 559,321 | 559,260 | 532,199 | 530,138 |
| Total capitalization | 1,280,766 | 1,275,156 | 1,271,561 | 1,241,902 | 1,229,442 |
| Net debt/total capitalization | 43.6% | 43.9% | 44.0% | 42.9% | 43.1% |
| Market valuation | 407,524 | 523,809 | 454,006 | 467,501 | 435,613 |
| Enterprise value | 964,556 | 1,080,457 | 1,010,649 | 996,360 | 962,368 |
Income Statement
(Amounts in thousands, except per share data)
| 3Q 2026 | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Rental income | 32,193 | 30,971 | 31,269 | 30,679 | 30,814 |
| Other operating interest | 250 | 253 | 255 | 267 | 272 |
| Total Revenues | 32,443 | 31,224 | 31,524 | 30,946 | 31,086 |
| Expenses | |||||
| Property operating | 5,975 | 5,865 | 6,369 | 6,014 | 5,930 |
| General and administrative (1) | 4,191 | 4,890 | 5,108 | 4,778 | 4,658 |
| Depreciation and amortization | 10,668 | 10,738 | 10,657 | 10,814 | 10,902 |
| Total Expenses | 20,834 | 21,493 | 22,134 | 21,606 | 21,490 |
| Other (Expense) Income | |||||
| Gain (loss), net of impairment, on the sale of real estate assets | -1,039 | 46 | -46 | 12,051 | -888 |
| Interest expense | -7,515 | -7,428 | -6,799 | -6,959 | -7,075 |
| Deferred income tax benefit (expense) | 12 | -23 | |||
| Interest and other income, net | 13 | 3 | 3 | 19 | 7 |
| Total Other (Expense) Income | -8,541 | -7,367 | -6,842 | 5,088 | -7,956 |
| Net Income | 3,068 | 2,364 | 2,548 | 14,428 | 1,640 |
| Net Income (Loss) Per Common Share - Basic & Diluted | 0.09 | 0.06 | 0.07 | 0.51 | 0.03 |
| Weighted Average Common Shares Outstanding | 27,070 | 27,016 | 26,991 | 26,953 | 26,934 |
| Dividends Declared, Per Common Share, In The Period | 0.33 | 0.48 | 0.4775 | 0.475 | 0.4725 |
| Non-cash vs. Cash: | |||||
| Non-cash (stock-based compensation) | 45.4 | 56.8 | 53.1 | 54.4 | 52.9 |
| Cash | 54.6 | 43.2 | 46.9 | 45.6 | 47.1 |
| As a % of Revenue: | |||||
| Non-cash (stock-based compensation) | 5.9 | 8.9 | 8.6 | 8.4 | 8 |
| Cash | 7.1 | 6.8 | 7.6 | 7 | 7.1 |
Income Statement
Net Operating Income (NOI) — (Amounts in thousands)
| 3Q 2026 | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | |
|---|---|---|---|---|---|
| Net income (loss) | 3,068 | 2,364 | 2,548 | 14,428 | 1,640 |
| General and administrative | 4,191 | 4,890 | 5,108 | 4,778 | 4,658 |
| Depreciation and amortization | 10,668 | 10,738 | 10,657 | 10,814 | 10,902 |
| (Gain) loss, net of impairment, on the sale of real estate assets | 1,039 | -46 | 46 | -12,051 | 888 |
| Interest expense | 7,515 | 7,428 | 6,799 | 6,959 | 7,075 |
| Deferred Income tax (benefit) expense | -12 | 23 | |||
| Interest and other income, net | -13 | -3 | -3 | -19 | -7 |
| NOI | 26,468 | 25,359 | 25,155 | 24,932 | 25,156 |
| Annualized NOI | 105,872 | 101,436 | 100,620 | 99,728 | 100,624 |
| EBITDAre And Adjusted EBITDAre | |||||
| Net income (loss) | 3,068 | 2,364 | 2,548 | 14,428 | 1,640 |
| Interest expense | 7,515 | 7,428 | 6,799 | 6,959 | 7,075 |
| Depreciation and amortization | 10,668 | 10,738 | 10,657 | 10,814 | 10,902 |
| Deferred Income tax (benefit) expense | -12 | 23 | |||
| (Gain) loss, net of impairment, on the sale of real estate assets | 1,039 | -46 | 46 | -12,051 | 888 |
| EBITDAre | 22,290 | 20,472 | 20,050 | 20,173 | 20,505 |
| Non-cash stock-based compensation expense | 1,903 | 2,778 | 2,711 | 2,599 | 2,465 |
| Adjusted EBITDAre | 24,193 | 23,250 | 22,761 | 22,772 | 22,970 |
| Adjusted EBITDAre Annualized | 96,772 | 93,000 | 91,044 | 91,088 | 91,880 |
Income Statement
Three Months Ended September 30, — (Unaudited; Dollars and shares in thousands, except per share amounts)
| Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Nine Months Ended September 30, – 2026 | Nine Months Ended September 30, – 2025 | |
|---|---|---|---|---|
| REVENUES | ||||
| Rental income | 32,193 | 30,814 | 94,433 | 90,672 |
| Other operating interest | 250 | 272 | 758 | -423 |
| 32,443 | 31,086 | 95,191 | 90,249 | |
| EXPENSES | ||||
| Property operating | 5,975 | 5,930 | 18,209 | 17,610 |
| General and administrative(1) | 4,191 | 4,658 | 14,189 | 20,317 |
| Depreciation and amortization | 10,668 | 10,902 | 32,063 | 32,724 |
| 20,834 | 21,490 | 64,461 | 70,651 | |
| OTHER (EXPENSE) INCOME | ||||
| Loss on sale and impairment of depreciable real estate assets, net of gains | -1,039 | -888 | -1,039 | -248 |
| Interest expense | -7,515 | -7,075 | -21,742 | -20,019 |
| Credit loss reserve | -8,672 | |||
Balance Sheet
(Amounts in thousands)
| 3Q 2026 | 2Q 2026 | 1Q 2026 | 4Q 2025 | 3Q 2025 | |
|---|---|---|---|---|---|
| Land and land improvements | 160,321 | 163,506 | 162,587 | 154,673 | 154,272 |
| Buildings, improvements, and lease intangibles | 1,058,175 | 1,077,295 | 1,074,680 | 1,047,743 | 1,035,070 |
| Personal property | 816 | 814 | 813 | 813 | 809 |
| Total real estate properties | 1,219,312 | 1,241,615 | 1,238,080 | 1,203,229 | 1,190,151 |
| Less accumulated depreciation | -308,944 | -301,593 | -290,958 | -280,316 | -272,481 |
| Total real estate properties, net | 910,368 | 940,022 | 947,122 | 922,913 | 917,670 |
| Cash and cash equivalents | 1,350 | 2,673 | 2,617 | 3,340 | 3,383 |
| Assets held for sale, net | 22,588 | 5,265 | 6,205 | ||
| Other assets, net | 66,105 | 60,900 | 60,354 | 59,239 | 60,003 |
| Total assets | 1,000,411 | 1,003,595 | 1,010,093 | 990,757 | 987,261 |
| Liabilities And Stockholders' Equity | |||||
| Debt, net | 558,382 | 559,321 | 559,260 | 532,199 | 530,138 |
| Accounts payable and accrued liabilities | 15,281 | 17,691 | 16,431 | 14,925 | 17,205 |
| Other liabilities, net | 13,308 | 12,341 | 13,059 | 14,246 | 13,095 |
| Total liabilities | 586,971 | 589,353 | 588,750 | 561,370 | 560,438 |
| Common stock | 287 | 287 | 286 | 285 | 285 |
| Additional paid-in capital | 724,107 | 722,454 | 719,819 | 717,450 | 714,890 |
| Cumulative net income | 98,757 | 95,689 | 93,325 | 90,777 | 76,349 |
| Accumulated other comprehensive gain | 13,028 | 9,047 | 7,395 | 6,691 | 7,568 |
| Cumulative dividends | -422,739 | -413,235 | -399,482 | -385,816 | -372,269 |
| Total stockholders’ equity | 413,440 | 414,242 | 421,343 | 429,387 | 426,823 |
| Total liabilities and stockholders' equity | 1,000,411 | 1,003,595 | 1,010,093 | 990,757 | 987,261 |
Balance Sheet
September 30, 2026 — (Dollars and shares in thousands, except per share amounts)
| September 30, 2026 – (Unaudited) | December 31, 2025 | |
|---|---|---|
| Real estate properties: | ||
| Land and land improvements | 160,321 | 154,673 |
| Buildings, improvements, and lease intangibles | 1,058,175 | 1,047,743 |
| Personal property | 816 | 813 |
| Total real estate properties | 1,219,312 | 1,203,229 |
| Less accumulated depreciation | -308,944 | -280,316 |
| Total real estate properties, net | 910,368 | 922,913 |
| Cash and cash equivalents | 1,350 | 3,340 |
| Assets held for sale, net | 22,588 | 5,265 |
| Other assets, net | 66,105 | 59,239 |
| Total assets | 1,000,411 | 990,757 |
| Liabilities | ||
| Debt, net | 558,382 | 532,199 |
| Accounts payable and accrued liabilities | 15,281 | 14,925 |
| Other liabilities, net | 13,308 | 14,246 |
| Total liabilities | 586,971 | 561,370 |
| Stockholders' Equity | ||
| Common stock, $0.01 par value; 450,000 shares authorized; 28,739 and 28,471 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | 287 | 285 |
| Additional paid-in capital | 724,107 | 717,450 |
| Cumulative net income | 98,757 | 90,777 |
| Accumulated other comprehensive gain | 13,028 | 6,691 |
| Cumulative dividends | -422,739 | -385,816 |
| Total stockholders’ equity | 413,440 | 429,387 |
| Total liabilities and stockholders' equity | 1,000,411 | 990,757 |
Cautionary Note Regarding Forward-Looking Statements... (truncated)tions or other forward-looking information. Such forward-looking statements reflect management’s current beliefs and are based on information currently available to management. Because forward-looking statements relate to future events, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the control of Community Healthcare Trust Incorporated (the "Company"). Thus, the Company’s actual results and financial condition may differ materially from those indicated in such forward-looking statements. Some factors that might cause such a difference include the following: general volatility of the capital markets and the market price of the Company’s common stock, changes in the Company’s business strategy, availability, terms and deployment of capital, changes in the real estate industry in general, interest rates or the general economy, adverse developments related to the healthcare industry, changes in governmental regulations, the degree and nature of the Company’s competition, the ability to consummate acquisitions under contract, catastrophic or extreme weather and other natural events and the physical effects of climate change, the occurrence of cyber incidents, effects on global and national markets as well as businesses resulting from increased inflation, changes in interest rates, supply chain disruptions, labor conditions, prolonged government shutdown or budgetary reductions or impasses, tariffs and global trade tensions, and/or international conflicts (including the conflicts in the Ukraine and in the Middle East), and the other factors described in the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, and the Company’s other filings with the Securities and Exchange Commission from time to time. Readers are therefore cautioned not to place undue reliance on the forward-looking statements contained herein which speak only as of the date hereof. The Company intends these forward-looking statements to speak only as of the time of this press release and undertakes no obligation to update forward-looking statements, whether as a result of new information, future developments, or otherwise, except as may be required by law.²